| Ms Evangeline Avellaneda Dancel, | |
|
209 23rd Ave, San Francisco, CA 94121-2008 | |
| (415) 845-3540 | |
| Not Available |
| Full Name | Ms Evangeline Avellaneda Dancel |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 209 23rd Ave, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013170620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 965 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Evangeline Avellaneda Dancel, 209 23rd Ave, San Francisco, CA 94121 Ph: (415) 845-3540 | Ms Evangeline Avellaneda Dancel, 209 23rd Ave, San Francisco, CA 94121-2008 Ph: (415) 845-3540 |
News Archive
Lux Biosciences, Inc. today announced that the U.S. Food and Drug Administration's Center of Drug Evaluation and Research has issued a Complete Response letter regarding the New Drug Application (NDA) for Luveniq™ (oral voclosporin) for the treatment of non-infectious uveitis.
U.N. Secretary-General Ban Ki-moon has urged more funding for the GAVI Alliance to help achieve its childhood vaccine targets and the related Millennium Development Goals (MDGs), TopNews reports.
Ashish Jha, assistant professor of health policy and management at the Harvard School of Public Health and colleagues from Brigham and Women's Hospital and the Boston Veterans Affairs Healthcare System, have for the first time assessed the quality of care in U.S. hospitals.
Merck, known as MSD outside the United States and Canada, announced today that data from the pivotal Phase III study with ZOSTAVAX(Zoster Vaccine Live) in adults ages 50 to 59 were published in the April 1 issue of Clinical Infectious Diseases.
A new study reveals that an enzyme linked with multiple disorders is also involved in the generation of toxic, neuron-killing protein fragments in Huntington's disease (HD). The research, published by Cell Press in the July 29 issue of Neuron, provides insight into Huntington's pathology and proposes new therapeutic strategies for this devastating incurable disease.
› Verified 9 days ago
Jacqueline Marie Mcintosh, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2111 43rd Ave, San Francisco, CA 94116 Phone: 561-762-8768 | |
Celeste Marty, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 5767 Mission St, San Francisco, CA 94112 Phone: 415-584-3294 | |
Kristy Kaule, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 408 22nd Ave, San Francisco, CA 94121 Phone: 415-677-7563 | |
Daniel Feliciano Ganoza, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4150 Clement St, San Francisco, CA 94121 Phone: 415-221-4810 | |
Miriam Crennan, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Parnassus Ave, Box 0228, San Francisco, CA 94143 Phone: 415-353-1740 | |
Jessica Taylor, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1849 Page St Apt 303, San Francisco, CA 94117 Phone: 951-567-3602 |